Trial Profile
A trial to compare real-world persistence of psoriasis patients in the US initiating apremilast or biologic therapy within 6 months
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 May 2016
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 31 May 2016 New trial record
- 25 May 2016 Results presented at the 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research